Dana-Farber Cancer Institute Boston, MA, USA
The Clinical Research Consent Writer is responsible for overseeing the authoring, development and overall quality assurance of the disease group’s consent documents submitted as part of the New Protocol Applications and any required consent amendments. This position will be the primary point person responsible for the collaboration / navigation with the DFCI IRB contacts, clinical trial sponsors, DFCI designated Principal Investigator and the disease group Clinical Research Manager to facilitate and streamline consent development within established timelines. Remote work may only be performed from New England states (CT, RI, MA, NH, VT, ME). Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care. We are united in our mission of conquering cancer, HIV/AIDS and related diseases. We strive to create an inclusive, diverse, and equitable environment where we provide compassionate and...